567 related articles for article (PubMed ID: 25008556)
21. Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts.
Baum R; Gravallese EM
Clin Rev Allergy Immunol; 2016 Aug; 51(1):1-15. PubMed ID: 26411424
[TBL] [Abstract][Full Text] [Related]
22. Reprint of: The Great Beauty of the osteoclast.
Cappariello A; Maurizi A; Veeriah V; Teti A
Arch Biochem Biophys; 2014 Nov; 561():13-21. PubMed ID: 25282390
[TBL] [Abstract][Full Text] [Related]
23. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.
Rajapurohitam V; Chalhoub N; Benachenhou N; Neff L; Baron R; Vacher J
Bone; 2001 May; 28(5):513-23. PubMed ID: 11344051
[TBL] [Abstract][Full Text] [Related]
24. Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP.
Islam R; Bae HS; Yoon WJ; Woo KM; Baek JH; Kim HH; Uchida T; Ryoo HM
J Cell Physiol; 2014 Dec; 229(12):2166-74. PubMed ID: 24891219
[TBL] [Abstract][Full Text] [Related]
25. Cytokines expressed in multinucleated cells: Paget's disease and giant cell tumors versus normal bone.
Mills BG; Frausto A
Calcif Tissue Int; 1997 Jul; 61(1):16-21. PubMed ID: 9192505
[TBL] [Abstract][Full Text] [Related]
26. The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders.
Saponaro F; Ferrisi R; Gado F; Polini B; Saba A; Manera C; Chiellini G
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830256
[TBL] [Abstract][Full Text] [Related]
27. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
28. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
29. Runx1-mediated regulation of osteoclast differentiation and function.
Soung do Y; Kalinowski J; Baniwal SK; Jacome-Galarza CE; Frenkel B; Lorenzo J; Drissi H
Mol Endocrinol; 2014 Apr; 28(4):546-53. PubMed ID: 24606124
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients.
Jobke B; Milovanovic P; Amling M; Busse B
Bone; 2014 Feb; 59():37-43. PubMed ID: 24211427
[TBL] [Abstract][Full Text] [Related]
31. Ostm1 Bifunctional Roles in Osteoclast Maturation: Insights From a Mouse Model Mimicking a Human OSTM1 Mutation.
Pata M; Vacher J
J Bone Miner Res; 2018 May; 33(5):888-898. PubMed ID: 29297601
[TBL] [Abstract][Full Text] [Related]
32. VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology.
Taylor RM; Kashima TG; Knowles HJ; Athanasou NA
Lab Invest; 2012 Oct; 92(10):1398-406. PubMed ID: 22906984
[TBL] [Abstract][Full Text] [Related]
33. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
[TBL] [Abstract][Full Text] [Related]
34. Transgenic mice with OIP-1/hSca overexpression targeted to the osteoclast lineage develop an osteopetrosis bone phenotype.
Shanmugarajan S; Irie K; Musselwhite C; Key LL; Ries WL; Reddy SV
J Pathol; 2007 Dec; 213(4):420-8. PubMed ID: 17940999
[TBL] [Abstract][Full Text] [Related]
35. Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption.
Rude RK; Kirchen ME; Gruber HE; Meyer MH; Luck JS; Crawford DL
Magnes Res; 1999 Dec; 12(4):257-67. PubMed ID: 10612083
[TBL] [Abstract][Full Text] [Related]
36. [Secondary osteoporosis or secondary contributors to bone loss in fracture. The relevance of immune system to bone metabolism].
Tanaka Y
Clin Calcium; 2013 Sep; 23(9):1265-70. PubMed ID: 23999361
[TBL] [Abstract][Full Text] [Related]
37. Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment.
Xu Q; Zhan P; Li X; Mo F; Xu H; Liu Y; Lai Q; Zhang B; Dai M; Liu X
J Cell Mol Med; 2021 Nov; 25(21):10126-10139. PubMed ID: 34651433
[TBL] [Abstract][Full Text] [Related]
38. The dietary anthocyanin delphinidin prevents bone resorption by inhibiting Rankl-induced differentiation of osteoclasts in a medaka (Oryzias latipes) model of osteoporosis.
Imangali N; Phan QT; Mahady G; Winkler C
J Fish Biol; 2021 Apr; 98(4):1018-1030. PubMed ID: 32155282
[TBL] [Abstract][Full Text] [Related]
39. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
Bordukalo-Nikšić T; Kufner V; Vukičević S
Front Immunol; 2022; 13():869422. PubMed ID: 35558080
[TBL] [Abstract][Full Text] [Related]
40. The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity.
Miyamoto T
Mod Rheumatol; 2006; 16(6):341-2. PubMed ID: 17164993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
